4//SEC Filing
NORTHCOTT JOHN 4
Accession 0001209191-21-070691
CIK 0000906709other
Filed
Dec 19, 7:00 PM ET
Accepted
Dec 20, 8:24 PM ET
Size
7.6 KB
Accession
0001209191-21-070691
Insider Transaction Report
Form 4
NORTHCOTT JOHN
SVP & Chief Commercial Officer
Transactions
- Award
Stock Option
2021-12-16+67,150→ 67,150 totalExercise: $13.22Exp: 2029-12-15→ Common Stock (67,150 underlying) - Award
Common Stock
2021-12-16+37,800→ 232,654 total
Footnotes (2)
- [F1]This stock award was acquired pursuant to a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive, upon vesting of the unit, one share of the Issuer's common stock. These RSUs vest over three years from the date of grant in substantially equal quarterly installments based on continued service.
- [F2]This stock option vests over four years from the date of grant in equal monthly installments based on continued service.
Documents
Issuer
NEKTAR THERAPEUTICS
CIK 0000906709
Entity typeother
Related Parties
1- filerCIK 0001615000
Filing Metadata
- Form type
- 4
- Filed
- Dec 19, 7:00 PM ET
- Accepted
- Dec 20, 8:24 PM ET
- Size
- 7.6 KB